Search

for
Search:

Research

5 / 1000+ results

Ixekizumab Improves Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis

research Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis

1 citations , April 2016 in “Journal of The American Academy of Dermatology”

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ixekizumab Shows Efficacy and Safety in Patients Who Failed Biweekly Etanercept Therapy: Analysis From UNCOVER-2, a Phase 3 Randomized Clinical Trial in Psoriasis

research Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis

April 2016 in “Journal of The American Academy of Dermatology”

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Anti-TNF Antibody-Induced Psoriasiform Skin Lesions in Patients with Inflammatory Bowel Disease Are Characterised by Interferon-γ-Expressing Th1 Cells and IL-17A/IL-22-Expressing Th17 Cells and Respond to Anti-IL-12/IL-23 Antibody Treatment

research Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

278 citations , March 2013 in “Gut”

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

research Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes

8 citations , July 2018 in “European Journal of Dermatology”

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

research Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration

3 citations , July 2018 in “European Journal of Dermatology”

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

View more "anti-il-17a monoclonal antibody" in research →

Learn

1 / 801 results

learn myristoyl pentapeptide-17

View more "anti-il-17a monoclonal antibody" in learn →

Clinics

4 / 4 results

Community Join

— no results

Try a deeper search in community →

Experts

— no results

Try a deeper search in experts →